HEAVEN TURNER: Open Payments
NPI 1649544305 · NEW SMYRNA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,619 in 72 payments from 17 companies in 2025. Trend: 2023 $1,345 · 2024 $1,020 · 2025 $1,619
Food & beverage: $1,602Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $300 |
| Insmed, Inc. | 12 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $217 |
| Regeneron Healthcare Solutions, Inc. | 4 | $122 |
| GlaxoSmithKline, LLC. | 5 | $118 |
| PFIZER INC. | 5 | $105 |
| United Therapeutics Corporation | 3 | $89 |
| GENZYME CORPORATION | 3 | $81 |
| Viatris Specialty LLC | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
Products named: DUPIXENT, Arikayce, TEZSPIRE, GLASSIA, Tyvaso, AIRSUPRA, YUPELRI, CUVITRU.
Industry payments across FL — which companies pay providers there.
